Pharmaceutical The European Medicines Agency has published its Brexit Preparedness Business Continuity Plan. The plan, which was endorsed by the Management Board at its June 2017 meeting, aims to safeguard continuity of EMA’s operations to protect public health while the Agency prepares for its relocation to a new host city and the departure of the United Kingdom from the European Union (EU). 17 October 2017